5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Expedient Organocatalytic Syntheses of 4-Substituted Pyrazolidines and Isoxazolidines

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The efficient organocatalytic synthesis of heterocyclic systems of biological relevance is a subject of growing interest. We have found that the pyrrolidine/benzoic acid-catalyzed reaction of α-substituted propenals such as methacrolein, 2-benzylpropenal and 2-( n-hexyl)propenal with activated hydrazines takes place in very good yields (83%–99.6%) under very mild conditions to afford 4-substituted pyrazolidin-3-ols (as diastereomer mixtures); subsequent oxidation with PCC affords the corresponding-4-substituted-3-pyrazolidinones in essentially quantitative yields. In a similar way, 4-substituted isoxazolidinones are obtained with N-Cbz-hydroxylamine as a reagent. The use of chiral diarylprolinol trimethylsilyl ethers as catalysts allows the synthesis of several of these compounds in optically active form, in some cases with excellent enantioselectivity (up to 96:4 er). A preliminary evaluation of the biological activity shows that some of these compounds exhibit interesting antibacterial and antifungal activities.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Antituberculosis drugs: ten years of research.

          Tuberculosis is today amongst the worldwide health threats. As resistant strains of Mycobacterium tuberculosis have slowly emerged, treatment failure is too often a fact, especially in countries lacking the necessary health care organisation to provide the long and costly treatment adapted to patients. Because of lack of treatment or lack of adapted treatment, at least two million people will die of tuberculosis this year. Due to this concern, this infectious disease was the focus of renewed scientific interest in the last decade. Regimens were optimized and much was learnt on the mechanisms of action of the antituberculosis drugs used. Moreover, the quest for original drugs overcoming some of the problems of current regimens also became the focus of research programmes and many new series of M. tuberculosis growth inhibitors were reported. This review presents the drugs currently used in antituberculosis treatments and the most advanced compounds undergoing clinical trials. We then provide a description of their mechanism of action along with other series of inhibitors known to act on related biochemical targets. This is followed by other inhibitors of M. tuberculosis growth, including recently reported compounds devoid of a reported mechanism of action.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Organocatalytic synthesis of spiro compounds via a cascade Michael–Michael-aldol reaction

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Organocatalytic asymmetric 5-hydroxyisoxazolidine synthesis: A highly enantioselective route to β-amino acids

                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                01 December 2016
                December 2016
                : 21
                : 12
                : 1655
                Affiliations
                [1 ]Division de Biotechnologie Industrielle, Centre National de Recherche en Biotechnologie, Ali Mendjli Nouvelle Ville, UV 03 BP E73, Constantine 25000, Algeria; t.yousfi@ 123456crbt.dz
                [2 ]Laboratoire de Chimie Appliquée, Département de Chimie, Université 8 Mai 1945—Guelma, BP 401, Guelma 24000, Algeria; merdesra@ 123456yahoo.fr
                [3 ]Institute for Molecular Biosciences, The University of Queensland, St. Lucia QLD 4072, Australia; a.elliott@ 123456imb.uq.edu.au
                [4 ]Département de Génie de l’Environnement, Faculté de Génie des Procédés, Université de Constantine 3, Ali Mendjli Nouvelle Ville, BP72, Constantine 25000, Algeria; messiad_h@ 123456yahoo.fr
                [5 ]Departament de Química Inorgànica i Orgànica, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1-11, Barcelona 08028, Catalonia, Spain
                Author notes
                [* ]Correspondence: amoyano@ 123456ub.edu ; Tel.: +34-93-402-1245
                Article
                molecules-21-01655
                10.3390/molecules21121655
                6274280
                27916954
                aa0121cd-559d-4f87-8675-696f30ed1b74
                © 2016 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 09 November 2016
                : 28 November 2016
                Categories
                Article

                asymmetric catalysis,isoxazolidinones,pyrazolidinones,organocatalysis,hydrazines,hydroxylamines,enals

                Comments

                Comment on this article